ARCHIVES

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 28 No. 42 | November 15, 2002

Download PDF Visit The Full Archive

Related Articles

Archival photos: Senator Ernest “Fritz” Hollings, namesake of MUSC Hollings Cancer Center

February 2, 2021

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993